Sientra closes sale of miraDry at $10M loss
Sientra, a Goleta-based plastic surgery device company specializing in breast implants, announced June 11 that it had closed the sale of miraDry, a non-surgical dermatological treatment. The $10 million sale brought half of what Sientra paid for the business four years ago. The miraDry system is an FDA-approved treatment to reduce underarm sweat, hair and Read More →
American Riviera moves up to top OTC marketplace
American Riviera Bank, the second-largest bank based in the Tri-Counties with nearly $1.1 billion in assets, began trading on the over-the-counter “Best Market” on June 14, a step up from its previous home on the “Pink” marketplace. Both marketplaces are run by OTC Markets Group. The Best Market, or OTCQX, is the highest tier for Read More →
Mission Produce earnings up, buoyed by rising avocado consumption
Rising avocado sales helped Mission Produce turn a profit in the second quarter of 2021 after posting a loss a year earlier. The Oxnard-based avocado distributor generated earnings of $7.4 million, or 10 cents per diluted share, for the quarter ended April 30, the company announced on June 10. In the same quarter last year, Read More →
Limoneira, Calavo both report earnings growth as produce industry continues recovery
Santa Paula-based agribusinesses Limoneira and Calavo Growers both reported positive earnings in their second quarter financial results released June 8, with both saying their earnings mark a return back to pre-pandemic form. Limoneira reported earnings of $1.5 million for the quarter, or 10 cents per share, up from a loss of $5.3 million in the Read More →
Semtech shares up after company reports income and revenue growth
Semtech Corp., a Camarillo semiconductor company specializing in Internet of Things applications, saw its income and revenue rise in the first quarter of fiscal year 2021-22, thanks in large part to growth in its wireless and sensing products market. Semtech saw revenue rise 28% year-over-year to $170.4 million, the company said when it released its Read More →
Amgen reaches billion-dollar licensing deal with Japanese firm
Amgen announced an agreement June 1 with Kyowa Kirin, a Japanese pharmaceutical company, to jointly develop and commercialize a human monoclonal antibody that Kyowa Kirin is developing to treat atopic dermatitis and other autoimmune diseases. The deal could be worth $1.25 billion or more. Amgen will led the development, manufacturing and commercialization for the treatment, Read More →